El Mundo on MSN1h
New advance against HIV: a single annual injection against the infection
Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...
Yearly Injection To Protect Against HIV? Gilead's Lenacapavir Shows Promise In Clinical Trial
A Lancet study shows promising results for an annual HIV prevention injection, lenacapavir. In Stage 1 trials, 40 HIV-negative participants had no significant side effects ...
WUSF Public Media54m
5 years since the pandemic started, long COVID patients are still hoping for a cure
They're pushing for more funding to find effective treatments. Researchers are finally starting to make headway but have a ...